+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics CXO Services Market - Global Forecast 2025-2030- Product Image
Biologics CXO Services Market - Global Forecast 2025-2030- Product Image
Sale

Biologics CXO Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6121982
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologics contract research and manufacturing (CXO) market is undergoing rapid transformation, with changes in regulatory environments, technology integration, and evolving partnership models redefining business strategies for industry leaders and stakeholders alike.

Market Snapshot: Biologics CXO Landscape at a Glance

The biologics CXO market is experiencing robust global momentum as biopharmaceutical companies seek comprehensive, integrated service models to enhance therapeutic development. Growing complexity in regulatory compliance, advanced digital platforms, and specialized production requirements are central drivers for new outsourcing partnerships. The latest market research report assesses the sector’s current size and growth trajectory, supported by a thorough analysis of service models, regional dynamics, and leading providers. Stakeholders gain actionable insights into avenues for streamlining operations, risk mitigation, and maximizing return on investment across the value chain.

Scope & Segmentation: Biologics CXO Market Coverage

This research delves into the multifaceted segmentation driving decision-making for senior executives and procurement teams:

  • Service Models: CDMO (Analytical Testing, Manufacturing, Process Development, Regulatory Consulting), CMO (Clinical Manufacturing, Commercial Manufacturing), CRO (Clinical Trial Management, Pharmacovigilance, Preclinical Services)
  • Applications: Cell Therapy (Commercial, Discovery, Phase I–III, Preclinical), Gene Therapy (same breakdown), Monoclonal Antibodies, Recombinant Proteins, Vaccines (each across the development spectrum)
  • Therapeutic Areas: Autoimmune, Cardiology, Infectious Diseases, Neurology, Oncology
  • Clinical Stages: Commercial, Discovery, Phases I–III, Preclinical
  • End User Types: Academia, Biopharmaceutical Companies, Research Institutions
  • Company Size: Large Pharma, Mid-Size Pharma, Small Biotech
  • Regional Coverage: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technology Deployments: Advanced digital ecosystems, continuous processing, predictive analytics, modular production platforms, single-use bioreactors, AI-powered surveillance, digital dashboards
  • Leading Companies: Lonza Group AG, Catalent, Inc., Thermo Fisher Scientific Inc., Samsung Biologics Co., Ltd., WuXi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Fujifilm Holdings Corporation, AGC Inc., Merck KGaA, Recipharm AB

Key Takeaways: Strategic Insights for CXO Decision-Makers

  • Integrated service platforms and evolving partnership models are enabling biopharma companies to accelerate product development and reduce operational risk.
  • Advanced digital integration and predictive analytics are transforming manufacturing agility and regulatory compliance management.
  • Therapeutic innovation in cell and gene therapy, monoclonal antibodies, and vaccines is prompting greater specialization and targeted outsourcing solutions.
  • Regional strategy diversification is critical, with investment in Asia-Pacific and EMEA responding to both cost and capability imperatives.
  • The competitive landscape is shaped by cross-functional collaborations, scalable infrastructure, and domain expertise that supports end-to-end drug development.
  • Providers that nurture multidisciplinary talent and digital skills ensure adaptability to emerging market and compliance requirements.

Tariff Impact: Navigating Regulatory and Cost Headwinds

The 2025 United States tariff policies have intensified global CXO supply chain complexity and squeezed operational margins, especially for companies reliant on imported inputs. Biopharma sponsors and service providers are responding by evaluating alternative sourcing, investing in regional production, and streamlining their procurement models to mitigate cost escalation and sustain project pipelines.

Primary Keyword: Biologics Contract Research and Manufacturing

Biologics contract research and manufacturing remains central to industry strategies, combining regulatory expertise, innovative science, and integrated digital technologies to drive progress in life sciences outsourcing.

Methodology & Data Sources

This analysis draws from in-depth expert interviews, case studies, regulatory guidance reviews, patent filings, and proprietary transaction and investment databases. Findings were validated through cross-functional panels and quantitative triangulation across multiple data streams.

Why This Report Matters

  • Plan with confidence using a comprehensive view of partner capabilities, risks, and opportunities across service models, therapeutic areas, and global regions.
  • Anticipate regulatory, economic, and technological forces shaping the value chain for biologics outsourcing and investment planning.
  • Benchmark leading companies, technology adoption, and evolving best practices to optimize competitive positioning and operational resilience.

Conclusion

This report provides high-impact, actionable insights to empower senior leaders in navigating the complex, interconnected world of biologics CXO services. The strategic guidance supports robust decision-making and ongoing business agility in an evolving marketplace.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of single-use bioreactor technologies by CXOs to enhance flexibility and cost efficiency in biologics production
5.2. Strategic collaborations between biologics manufacturers and specialized CDMOs for advanced cell and gene therapy pipeline acceleration
5.3. Integration of digital twin and data analytics platforms in biologics contract development and manufacturing operations to improve process optimization
5.4. Growing demand for continuous bioprocessing solutions in large-scale monoclonal antibody production by CDMO service providers
5.5. Expansion of biosimilar manufacturing capabilities by CXO partners in emerging markets to address cost-sensitive biologics needs
5.6. Implementation of modular plug-and-play facility designs to reduce time to scale for clinical and commercial biologics manufacturing
5.7. Increasing regulatory harmonization initiatives influencing biologics CXO service quality standards across global markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics CXO Services Market, by Service Model
8.1. Introduction
8.2. CDMO
8.2.1. Analytical Testing
8.2.2. Manufacturing
8.2.3. Process Development
8.2.4. Regulatory Consulting
8.3. CMO
8.3.1. Clinical Manufacturing
8.3.2. Commercial Manufacturing
8.4. CRO
8.4.1. Clinical Trial Management
8.4.2. Pharmacovigilance
8.4.3. Preclinical Services
9. Biologics CXO Services Market, by Application
9.1. Introduction
9.2. Cell Therapy
9.2.1. Commercial
9.2.2. Discovery
9.2.3. Phase I
9.2.4. Phase II
9.2.5. Phase III
9.2.6. Preclinical
9.3. Gene Therapy
9.3.1. Commercial
9.3.2. Discovery
9.3.3. Phase I
9.3.4. Phase II
9.3.5. Phase III
9.3.6. Preclinical
9.4. Monoclonal Antibodies
9.4.1. Commercial
9.4.2. Discovery
9.4.3. Phase I
9.4.4. Phase II
9.4.5. Phase III
9.4.6. Preclinical
9.5. Recombinant Proteins
9.5.1. Commercial
9.5.2. Discovery
9.5.3. Phase I
9.5.4. Phase II
9.5.5. Phase III
9.5.6. Preclinical
9.6. Vaccines
9.6.1. Commercial
9.6.2. Discovery
9.6.3. Phase I
9.6.4. Phase II
9.6.5. Phase III
9.6.6. Preclinical
10. Biologics CXO Services Market, by Therapeutic Area
10.1. Introduction
10.2. Autoimmune
10.3. Cardiology
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
11. Biologics CXO Services Market, by Clinical Stage
11.1. Introduction
11.2. Commercial
11.3. Discovery
11.4. Phase I
11.5. Phase II
11.6. Phase III
11.7. Preclinical
12. Biologics CXO Services Market, by End User
12.1. Introduction
12.2. Academia
12.3. Biopharmaceutical Companies
12.4. Research Institutions
13. Biologics CXO Services Market, by Company Size
13.1. Introduction
13.2. Large Pharma
13.3. Mid-Size Pharma
13.4. Small Biotech
14. Americas Biologics CXO Services Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biologics CXO Services Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biologics CXO Services Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Lonza Group AG
17.3.2. Catalent, Inc.
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. Samsung Biologics Co., Ltd.
17.3.5. WuXi Biologics (Cayman) Inc.
17.3.6. Boehringer Ingelheim International GmbH
17.3.7. Fujifilm Holdings Corporation
17.3.8. AGC Inc.
17.3.9. Merck KGaA
17.3.10. Recipharm AB
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICS CXO SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOLOGICS CXO SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOLOGICS CXO SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOLOGICS CXO SERVICES MARKET: RESEARCHAI
FIGURE 28. BIOLOGICS CXO SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOLOGICS CXO SERVICES MARKET: RESEARCHCONTACTS
FIGURE 30. BIOLOGICS CXO SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICS CXO SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY ACADEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MID-SIZE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY MID-SIZE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL BIOLOGICS CXO SERVICES MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS BIOLOGICS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES BIOLOGICS CXO SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 225. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 226. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 227. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 228. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 229. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 230. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 231. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 232. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 233. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 236. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 237. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 238. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 239. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 240. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 241. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 242. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 243. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 244. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 245. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 246. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 247. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 248. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 249. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 252. CANADA BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 273. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 274. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 275. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 276. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 277. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 280. MEXICO BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL BIOLOGICS CXO SERVICES MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY SERVICE MODEL, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CDMO, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CMO, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CRO, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA BIOLOGICS CXO SERVICES MARKET SIZE, BY CLINICAL STAGE, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA BIOLOGICS CXO SE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biologics CXO Services market report include:
  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Samsung Biologics Co., Ltd.
  • WuXi Biologics (Cayman) Inc.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Holdings Corporation
  • AGC Inc.
  • Merck KGaA
  • Recipharm AB

Related Topics

Related Reports

Biologics & Biosimilars CXO Services Market - Global Forecast 2025-2030 - Product Image

Biologics & Biosimilars CXO Services Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Inhalable Biologics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Inhalable Biologics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 132 Pages
  • Global
From
Biologics Outsourcing Market - Global Forecast 2025-2030 - Product Image

Biologics Outsourcing Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Regulatory Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service, By Phase, By Modality, Phase by Service, Phase by Modality, Modality by Service, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Leading Players and Sales Forecast - Product Image

Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental Principle, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Leading Players and Sales Forecast

  • Report
  • 997 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.